Contact
Please use this form to send email to PR contact of this press release:
INNATE PHARMA : Preliminary activity observed of the combination of monalizumab and durvalumab in patients with colorectal cancer
TO:
Please use this form to send email to PR contact of this press release:
INNATE PHARMA : Preliminary activity observed of the combination of monalizumab and durvalumab in patients with colorectal cancer
TO: